Live news related to NEOVACS stock (FR0014010856): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on NEOVACS mainly cover M&A activity. This page lists the articles published on NEOVACS stock to track the share price, company announcements and any item likely to influence market perception.
The funding, awarded under France 2030, aims to sustain the partnership initiated in May 2024 between the Suresnes biotech company and the academic la…
The biopharmaceutical company based in Suresnes announced on September 30, 2026 that it has received Lab&Co funding, operated by the ValoCité Universi…
The biopharmaceutical group has linked the scientific publication of phase III results for PXT3003 in China to a binding letter of intent received fro…
Biopharmaceutical company Néovacs informed the market of the status of its dilutive financing line. The monthly drawdown scheduled for August 2026 was…
The French biopharmaceutical company has accepted a binding letter of intent for the sale of part of its intellectual property, focused on the PXT3003…
French biotech company Neovacs announced on Tuesday the filing of a patent application protecting a new family of proprietary lipids, co-developed wit…
